Natera® is a worldwide genetic testing and diagnostics company that’s changing how doctors and patients manage genetic disease. Our team includes scientists, biostatisticians, researchers, and talented laboratory professionals from around the globe.
Natera develops and commercializes non-invasive methods for analyzing DNA. We operate a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California, and offer a host of proprietary genetic testing services.
Since 2009, Natera has launched seven molecular screening tests, many of which are available through major health plans accounting for more than 140 million covered lives in the United States. The company’s own robust laboratory processes thousands of genetic tests per month.
We're driven by a passion for elevating the science and utility of genetic testing.
Signatera is a personalized circulating tumor DNA (ctDNA) technology that analyzes and tracks mutations specific to an individual's tumor, for research use only (RUO) by oncology researchers and biopharmaceutical companies. The assay have a VAF detection down to 0.01% while maintaining a specificity of close to 100%.
Natera® is driven by a passion for elevating the science of reproductive testing. We offer highly accurate solutions for noninvasive prenatal testing (NIPT), genetic-carrier screening, preimplantation genetic testing (PGD/PGS), and miscarriage testing.
Natera has not received any reviews.
Natera has not received any endorsements.